[Federal Register Volume 63, Number 154 (Tuesday, August 11, 1998)]
[Rules and Regulations]
[Page 42699]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-21470]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 814
[Docket No. 98N-0168]
Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review
AGENCY: Food and Drug Administration, HHS.
ACTION: Direct final rule; withdrawal.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) published, in the
Federal Register of April 27, 1998 (63 FR 20530), a direct final rule
to implement the amendments to the premarket approval provisions of the
Federal Food, Drug, and Cosmetic Act, as amended by the Food and Drug
Administration Modernization Act of 1997 (FDAMA). The comment period
closed on July 13, 1998. FDA is withdrawing the direct final rule
because the agency received significant adverse comment.
DATES: The direct final rule published at 63 FR 20530, April 27, 1998,
is withdrawn on August 11, 1998.
FOR FURTHER INFORMATION CONTACT: Kathy M. Poneleit, Center for Devices
and Radiological Health (HFZ-402), Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850, 301-594-2186.
Therefore, under the Federal Food, Drug, and Cosmetic Act, and
under authority delegated to the Commissioner of Food and Drugs, the
direct final rule published on April 27, 1998, at 63 FR 20530 is
withdrawn.
Dated: August 5, 1998.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 98-21470 Filed 8-10-98; 8:45 am]
BILLING CODE 4160-01-F
